Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 798-802, June 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolberg, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolberg, W. H.

Inhibition of Migration of Human Autogenous and Allogeneic Leukocytes by Extracts of Patients' Cancers1

William H. Wolberg

Division of Clinical Oncology and Department of Surgery, University of Wisconsin Medical Center, Madison, Wisconsin 53706

Studies have shown the importance of the delayed hypersensitivity reaction in the body's defense against cancer. Production of migration-inhibitory factors is characteristic of the delayed hypersensitivity reaction. Delayed hypersensitivity to chemically induced tumors has been demonstrated in animals by inhibition of macrophage migration.

In our study, preparations from 19 of 21 human tumors inhibited leukocyte migration. Some preparations were cytotoxic to both autogenous and allogeneic migrating leukocytes. Growth of heterologous hepatoma cells in tissue culture was not inhibited by some preparations that inhibited leukocyte migration. It appears that both cytotoxic and migration-inhibiting substances can be liberated by tumor-leukocyte interaction. Such factors may prevent interaction between cancer cells and human tumors and thereby inhibit the cellular immune response in cancer patients.

1 This work was supported by USPHS Grant CA 05953.

Received 11/24/70. Accepted 2/ 5/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.